The increasing prevalence of various types of cancer around world is driving the global oncology molecular diagnostics market, says Fortune Business Insights in a report, titled “Oncology Molecular Diagnostics Market Size, Share and Global Trend By Product (Instruments, Reagents), By Cancer Type (Blood Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Cervical Cancer), By Technology (Polymerase Chain Reaction, Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification), By End User (Hospitals, Diagnostic Centers) and Geography Forecast till 2026.” The rising shift towards precision medicine is expected to enable the growth of the global oncology molecular diagnostics market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Major Leading Players Mentioned:

  • Abbott
  • Becton
  • Dickinson and Company
  • Hoffmann-La Roche Ltd
  • Cepheid
  • Bayer AG
  • Agilent Technologies
  • Danaher
  • Hologic
  • Sysmex Corporation
  • Siemens Healthcare GmbH.

Increasing Demand for Automated and Advanced Diagnostic Will Propel Growth

The increasing prevalence of numerous cancer is likely to back the growth of the global automated and advanced diagnostic market revenue. The rising shift towards precision medicine and increasing demand for preventive care is expected to boost the global oncology molecular diagnostics market growth. Further, increasing demand for automated and advanced diagnostic techniques for cancer is also expected to aid the global oncology molecular diagnostics market shares. According to the World Health Organization, the number of cancer cases in the world in 2018 is estimated to be 18.0 million, which is expected to further fuel the global oncology molecular diagnostics market.

Furthermore, favourable health reimbursement policies are likely to foster the growth of the global oncology molecular diagnostics market. Moreover, Acquisition and mergers by key companies is predicted to stimulate the global oncology molecular diagnostics market growth during the forecast period. For instance, cancer Genetics announced merger with NovellusDx as a result of which Cancer Genetics portfolio of oncology test and services will combine with next-generation sequencing and other technologies of NovellusDx. Similarly, Biodesix, Inc., announced the acquisition of Integrated Diagnostics, Inc. which resulted in acquisition of the company oncology product namely XL2 test. Additionally, the launch of MammaTyper is also expected to propel growth of the global oncology molecular diagnostics market. For instance, BioNTech SE launched MammaTyper, a molecular diagnostic test for breast cancer which was developed in collaboration with Stratifyer. However, high costs associated with molecular diagnostics, budgetary limitations, and the requirement of the sophisticated facility are the major factors predicted to hinder the growth of the global oncology molecular diagnostics Industry.

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-molecular-diagnostics-market-101145

Rapid Adoption of Advanced Diagnostics Techniques Will Boost Growth in North America

Geographically, the global oncology molecular diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle and Africa. North America is expected to dominate the global oncology molecular diagnostics market during the forecast period owing to the rapid adoption of advanced diagnostics techniques and sedentary lifestyles. According to the American Cancer Society (ACS), melanoma or skin cancer is the most common type of cancer occurring in the U.S. and is estimated that approximately 91,270. Favourable health reimbursement policies will further augment growth in the region. In Asia Pacific, the oncology molecular diagnostics market is predicted to grow at a significant rate owing to the growing geriatric population and rising research on precision medicines. The high unmet cancer needs are also expected to enable growth in Asia Pacific.

Speak to Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-molecular-diagnostics-market-101145

Related Reports:

Urinary Drainage Bags Market Condition

Urinary Drainage Bags Market Impact

Urinary Drainage Bags Market Impact

Urinary Drainage Bags Market Shares

Urinary Drainage Bags Market Trends

Urinary Drainage Bags Market Drivers

Urinary Drainage Bags Market Increase

Urinary Drainage Bags Market Rise

Urinary Drainage Bags Market CAGR Value

Urinary Drainage Bags Market Covid Effect

Urinary Drainage Bags Market Condition

Urinary Drainage Bags Market Search Analysis

Urinary Drainage Bags Market Growth Analysis

Urinary Drainage Bags Market Revenue

Urinary Drainage Bags Market Manufacturers

Urinary Drainage Bags Market Drivers

Hepatitis C Drug Market Drivers

Hepatitis C Drug Market Research Methodology

Hepatitis C Drug Market Future Growth

Hepatitis C Drug Market Devlopment Strategy

Hepatitis C Drug Market Industry

Hepatitis C Drug Market Overview

Hepatitis C Drug Market Segments

Hepatitis C Drug Market Competitive Landscape

Hepatitis C Drug Market Demand

Hepatitis C Drug Market Key Players

Hepatitis C Drug Market Business Opportunities

Hepatitis C Drug Market Analysis

Hepatitis C Drug Market Growth

Hepatitis C Drug Market Trends

Hepatitis C Drug Market Share

Hepatitis C Drug Market Size

Leave a Reply

Your email address will not be published. Required fields are marked *